Beta Bionics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	35.08	30.43	26.57	27.68
Short-Term Investments	214.65	73.14	70.18	-
Cash & Short-Term Investments	249.72	103.58	96.75	27.68
Cash Growth	158.12%	7.06%	249.58%	-
Receivables	11.4	12	4.45	-
Inventory	17.32	13.32	1.25	-
Prepaid Expenses	5.34	2.98	0.91	0.54
Other Current Assets	2.3	1.05	0.28	0.25
Total Current Assets	286.08	132.92	103.62	28.47
Property, Plant & Equipment	12.5	11.42	6.2	6.87
Long-Term Deferred Charges	-	5.05	-	-
Other Long-Term Assets	0.24	0.25	0.22	0.19
Total Assets	329.97	149.65	110.04	35.53
Accounts Payable	3.42	2.85	1.17	0.43
Accrued Expenses	10.39	13.33	7.07	6.14
Current Portion of Leases	1.52	1.53	1.22	0.98
Current Unearned Revenue	1.14	0.94	0.09	-
Other Current Liabilities	3.02	2.5	1.05	1.32
Total Current Liabilities	19.49	21.15	10.61	8.87
Long-Term Leases	5.17	5.73	3	3.16
Long-Term Unearned Revenue	2.67	1.86	0.26	-
Other Long-Term Liabilities	1.01	44.9	37.57	10.5
Total Liabilities	28.34	73.63	51.43	22.53
Common Stock	0	0	0	0
Additional Paid-In Capital	643.74	51.31	26.42	15.53
Retained Earnings	-342.26	-296.74	-229.66	-185.57
Comprehensive Income & Other	0.15	0.07	0.14	-
Total Common Equity	301.63	-245.36	-203.11	-170.03
Shareholders' Equity	301.63	76.01	58.61	13
Total Liabilities & Equity	329.97	149.65	110.04	35.53
Total Debt	6.69	7.26	4.22	4.13
Net Cash (Debt)	243.03	96.32	92.52	23.54
Net Cash Growth	162.68%	4.11%	293.01%	-
Net Cash Per Share	11.11	15.13	17.44	4.71
Filing Date Shares Outstanding	43.47	43.35	5.03	5
Total Common Shares Outstanding	43.47	6.67	5.03	5
Working Capital	266.59	111.78	93.02	19.59
Book Value Per Share	6.94	-36.80	-40.39	-34.02
Tangible Book Value	301.63	-245.36	-203.11	-170.03
Tangible Book Value Per Share	6.94	-36.80	-40.39	-34.02
Machinery	8.39	7.48	5.78	5.56
Construction In Progress	3.15	1.74	0.17	0.18
Leasehold Improvements	0.83	0.81	0.95	0.95

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q